The report believes that JXR has good prospects for business...
The report believes that JXR has good prospects for business recovery. The company's development momentum is positive, and there is a rigid demand for assisted reproduction, with high-quality growth prospects globally. However, risks such as new business expansion, unexpected medical insurance cost control, and medical accidents still need attention.
Guosen Securities: Maintain a "buy" rating on JXR. Strong recovery in initial consultation and frozen egg business in the Greater Bay Area.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment